2269 logo

Meiji Holdings Co., Ltd. Stock Price

TSE:2269 Community·JP¥961.6b Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

2269 Share Price Performance

JP¥3,547.00
481.00 (15.69%)
JP¥3,492.86
Fair Value
JP¥3,547.00
481.00 (15.69%)
1.6% overvalued intrinsic discount
JP¥3,492.86
Fair Value
Price JP¥3,547.00
AnalystConsensusTarget JP¥3,492.86

2269 Community Narratives

AnalystConsensusTarget·
Fair Value JP¥3.49k 1.6% overvalued intrinsic discount

Analysts Reaffirm Meiji Holdings Price Target as Valuation Metrics Stay Steady Amid Singapore Plans

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative

Trending Discussion

Updated Narratives

2269 logo

2269: Dividend Increase And Mixed Segment Outlook Will Support Fair Value

Fair Value: JP¥3.49k 1.6% overvalued intrinsic discount
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Flawless balance sheet average dividend payer.

1 Risk
2 Rewards

Meiji Holdings Co., Ltd. Key Details

JP¥1.2t

Revenue

JP¥817.4b

Cost of Revenue

JP¥342.5b

Gross Profit

JP¥297.1b

Other Expenses

JP¥45.4b

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Feb 12, 2026
167.50
29.53%
3.91%
12.7%
View Full Analysis

About 2269

Founded
1916
Employees
17231
CEO
Katsunari Matsuda
WebsiteView website
www.meiji.com

Meiji Holdings Co., Ltd., through its subsidiaries, engages in the manufacture and sale of dairy products, confectionery food products and pharmaceuticals in Japan and internationally. The company operates through two segments, Food and Pharmaceuticals. The Food segment provides yogurt, milk, beverages, cheese, butter, margarine, cream, ice cream, prepared food, chocolate, gummy candy, sports nutrition, infant milk, liquid food, beauty products, feed, sugar, and corn sweeteners. The Pharmaceutical segment offers drugs for infectious and central nervous system disorders, vaccines, blood plasma products, generic drugs, and animal health products. Meiji Holdings Co., Ltd. was founded in 1916 and is headquartered in Tokyo, Japan.

Recent 2269 News & Updates

Recent updates

No updates